ALKS

#960
Alkermes plc - Ordinary Shares
42.2 0 USD
+5.66%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
42.10
42.81
年范围
25.16
42.81
日变化
+5.66%
每月变动
+24.52%
6个月变化
+44.03%
年变化
+39.50%
前一天收盘价
39.9 4
Open
42.4 6
最低价
42.1 0
High
42.8 1
交易量
2 644
展开完整图表 完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 7.03 B
  • Employee 2 050
  • Founded 1987
  • CEO Richard F. PopsRichard F. Pops
  • Website www.alkermes.com
  • Headquarter Ireland
  • FIGI UNKNOWN
  • Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
39.29
市销率
3.8

Alkermes plc - Ordinary Shares

Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio.

新闻